Status:
UNKNOWN
Does tDCS is Effective in the Prophylactic Treatment of Migraine
Lead Sponsor:
Universidade Federal de Pernambuco
Conditions:
Migraine
Eligibility:
All Genders
18-40 years
Phase:
PHASE2
Brief Summary
Migraine has been described as one of the most common neurological diseases, with high social and economic impact. Despite the high prevalence, the pathophysiology of migraine is still unknown, severa...
Eligibility Criteria
Inclusion
- Inclusion criteria for migraine patients:
- Age must be between 18 to 40 years
- Gender: male and female
- Diagnosis must meet the 2004 IHS criteria for migraine without aura and migraine with aura
- Duration of the disease must be at least 12 months
- Patients had no preventative medication consistently for at least six months prior to study initiation.
- Inclusion criteria for healthy individuals
- Age must be between 18 to 40 years
- Gender: male and female
- Individuals who have not filed headache crisis in the last year assessed according to the 2004 IHS criteria
- Exclusion criteria
- Pregnant woman
- Individuals with clinical evidence of brain injury
- Metallic implant head
- Pacemaker
- History of seizure and chronic pain associated with other pathologies
Exclusion
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01886274
Start Date
October 1 2012
End Date
October 1 2014
Last Update
May 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Applied Neuroscience Laboratory-LANA
Recife, Pernambuco, Brazil, 50740-560